BridgeMD
New treatment option for Primary Malignant Brain Tumor
Official title FearLess in NeuroOncology
ClinicalTrials.gov ID: NCT06989086
What this study is testing
- What it's testing
- The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients:
- Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
- \>2 weeks post-cranial resection or biopsy
- Elevated Fear of Recurrence Distress Rating
- Primarily English speaking
You likely can't join if
- Patient / Caregiver Exclusion:
- Cognitive impairment that might prohibit active intervention engagement
- Inability to understand and provide informed consent
- Inability to attend virtual sessions due to unstable or no internet connection
See the full eligibility criteria
- Patients:
- Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
- \>2 weeks post-cranial resection or biopsy
- Elevated Fear of Recurrence Distress Rating
- Primarily English speaking
- \>/= 18 years of age at the time of enrollment Caregivers:
- nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)
- Elevated Fear of Recurrence Distress Rating
- Primarily English speaking
- \>/= 18 years of age at the time of enrollment
- Patient / Caregiver Exclusion:
- Cognitive impairment that might prohibit active intervention engagement
- Inability to understand and provide informed consent
- Inability to attend virtual sessions due to unstable or no internet connection
The study team makes the final eligibility decision.
Where it's taking place
- Richmond, Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Richmond, Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.